47 related articles for article (PubMed ID: 31351207)
1. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis.
Bing ZT; Yang GH; Xiong J; Guo L; Yang L
IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479
[TBL] [Abstract][Full Text] [Related]
2. Molecular monitoring by CDKN2A/p16INK4A and RB1 gene methylation in breast cancer.
Queiroz LF; Silva MSDME; Rosman FC; Rosas SLB; Souza HSP; Carvalho MDGDC
Rev Assoc Med Bras (1992); 2024; 70(4):e20231358. PubMed ID: 38716944
[TBL] [Abstract][Full Text] [Related]
3. Surprisal analysis of Glioblastoma Multiform (GBM) microRNA dynamics unveils tumor specific phenotype.
Zadran S; Remacle F; Levine R
PLoS One; 2014; 9(9):e108171. PubMed ID: 25265448
[TBL] [Abstract][Full Text] [Related]
4. JCDSA: a joint covariate detection tool for survival analysis on tumor expression profiles.
Wu Y; Liu Y; Wang Y; Shi Y; Zhao X
BMC Bioinformatics; 2018 May; 19(1):187. PubMed ID: 29843599
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free miRNAs as Non-Invasive Biomarkers in Brain Tumors.
Beylerli O; Encarnacion Ramirez MJ; Shumadalova A; Ilyasova T; Zemlyanskiy M; Beilerli A; Montemurro N
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761255
[TBL] [Abstract][Full Text] [Related]
6. The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?
Aloizou AM; Pateraki G; Siokas V; Mentis AA; Liampas I; Lazopoulos G; Kovatsi L; Mitsias PD; Bogdanos DP; Paterakis K; Dardiotis E
Toxicol Rep; 2020; 7():1514-1530. PubMed ID: 33251119
[TBL] [Abstract][Full Text] [Related]
7. Increased
García-Martínez A; López-Muñoz B; Fajardo C; Cámara R; Lamas C; Silva-Ortega S; Aranda I; Picó A
Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32316225
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.
Shea A; Harish V; Afzal Z; Chijioke J; Kedir H; Dusmatova S; Roy A; Ramalinga M; Harris B; Blancato J; Verma M; Kumar D
Cancer Med; 2016 Aug; 5(8):1917-46. PubMed ID: 27282910
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.
Henriksen M; Johnsen KB; Andersen HH; Pilgaard L; Duroux M
Mol Neurobiol; 2014 Dec; 50(3):896-913. PubMed ID: 24619503
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme.
Sippl C; Teping F; Ketter R; Braun L; Tremmel L; Schulz-Schaeffer W; Oertel J; Urbschat S
World Neurosurg; 2019 Dec; 132():e900-e908. PubMed ID: 31351207
[TBL] [Abstract][Full Text] [Related]
11. miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme.
Sippl C; Ketter R; Braun L; Teping F; Schoeneberger L; Kim YJ; List M; Nakhoda A; Wemmert S; Oertel J; Urbschat S
Acta Neurochir (Wien); 2019 Nov; 161(11):2299-2309. PubMed ID: 31478117
[TBL] [Abstract][Full Text] [Related]
12. Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors.
Ferreira WA; Araújo MD; Anselmo NP; de Oliveira EH; Brito JR; Burbano RR; Harada ML; Borges Bdo N
PLoS One; 2015; 10(8):e0137259. PubMed ID: 26317630
[TBL] [Abstract][Full Text] [Related]
13. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.
Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q
Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063
[TBL] [Abstract][Full Text] [Related]
14. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
